Libuna, Jan Zamroe P.
HRN: 24-88-08 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2024
CEFTRIAXONE 1G (VIAL)
04/17/2024
04/24/2024
IV
1g
Q12
For Surgery
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes